Medscape
Several new clinical trials in breast cancer have opened in recent months. Perhaps one of your patients could benefit from taking part? Human epidermal growth factor receptor 2–positive (HER2+) or HER2-low unresectable or metastatic breast cancer. Adults with this type of breast cancer who have received one to three chemotherapies may be eligible for a …
Read More
New Trials in Breast Cancer: Could Your Patient Benefit?
Tomi Haslett
11:38
Several new clinical trials in breast cancer have opened in recent months. Perhaps one of your patients could benefit from taking part? Human epidermal growth factor receptor 2–positive (HER2+) or HER2-low unresectable or metastatic breast cancer. Adults with this type of breast cancer who have received one to three chemotherapies may be eligible for a
